Risk factors and poor prognostic factors of preeclampsia in Ibn Rochd University Hospital of Casablanca: about 401 preeclamptic cases

Risk factors and poor prognostic factors of preeclampsia in Ibn Rochd University Hospital of Casablanca: about 401 preeclamptic cases

Meriem Benfateh^1,&, Souadou Cissoko¹, Houssine Boufettal², Jean-Jacques Feige³, Naima Samouh², Touria Aboussaouira¹, Mohamed Benharouga⁴, Nadia Alfaidy³

 

¹Unité de Culture Cellulaire, CED, Faculté de Médecine et de Pharmacie, Hassan II University of Casablanca, Maroc, ²Service C de Gynécologie, CHU Ibn Rochd, Faculté de Médecine et de Pharmacie, Hassan II University of Casablanca, Maroc, ³Institut de Biosciences et Biotechnologie du CEA de Grenoble, Unité U1036 INSERM, Grenoble, France, ⁴Commissariat à l'Energie Atomique (CEA), DSV-iRTSV, 17 rue des Martyrs, France-Université Grenoble-Alpes, Centre National de la Recherche Scientifique, UMR 5249, 38054 Grenoble Cedex 9, France

 

 

^&Corresponding author
Meriem Benfateh, Unité de Culture Cellulaire, CED, Faculté de Médecine et de Pharmacie, Hassan II University of Casablanca, Maroc

 

 

 

 

Preeclampsia is a gestational pathology, defined as the association of pregnancy-induced hypertension (BP≥140/90mmHg) and proteinuria of (≥300mg/24h) after 20 weeks of gestation [1]. It affects approximately 0.5 to 7% of pregnancies [2] and is a leading cause of maternal and fetal morbidity and mortality worldwide [3]. This rate is higher in low socioeconomic status and areas with high prevalence of cardiovascular diseases [4]. Several risk factors have been proposed to characterize women at high risk of preeclampsia, including nulliparity, older age, chronic hypertension, and pregnancy diabetes mellitus [5]. Moreover, patients with preeclampsia are at increased risk of developing cardiovascular disease, renal and neurological disorders later in life which determines the risk profile of the child' future health [6]. It is a complication of pregnancy, which also has long-term effects on maternal health [7] and is one of the major cause of premature delivery usually medically indicated for the benefit of the mother in developed countries, which leads to infant morbidity and substantial excess health care expenditure [8]. Since, the mechanisms of diseases onset remains unclear and currently, no Therapeutic approaches are available to either treat or prevent preeclampsia, which just still based on the prevention of the malignant hypertension and ending the pregnancy [1]. Furthermore, there is no real predictive factors of this pathology [9]. However, the identification of prognostic factors of pregnant women at risk of preeclampsia could be of great importance so as to improve the prognosis of our patients and their childbirths. Incidence of preeclampsia throughout the world varies according to the authors, the studied population and the definition used. It also differs between different ethnic group, from one country to another and even from one region to another within the same country. In the US, the frequency had increased from 3.4% to 3.8% over the last 30 years [10]. In France, the incidence of preeclampsia was estimated to 1-3% in nulliparous patients and between 0.5 to 1.5% in multiparous patients [11]. In Spain, the frequency was 1 to 2% [4]. In Anglo-Saxon countries, the incidence ranges from 3 to 7% in primiparae and 1 to 3% in multiparous [3]. In black Africa, the prevalence of preeclampsia was of around 25% [12]. Frequency of preeclampsia was found to be 44% in sub-Saharan Africa [13]. In a Senegalese study, a frequency of 14.9% was found in relation to all the hypertensive states associated with pregnancy [14]. In Morocco, the exact epidemiological situation of preeclampsia remains little investigated. The aim of this work is to evaluate the epidemiological profile of preeclampsia in Casablanca and to identify risk factors as well as factors of poor maternal and fetal prognosis factors by a retrospective study including 401 preeclamptic patients.

 

 

Retrospective study was conducted during the two-year period from the first January 2010 to 31 December 2011, at the Department of Gynecology-Obstetrics "C" Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca. Included patients were those having pre-eclampsia defined by hypertension (BP≥140/90mmHG) associated with significant proteinuria (≥0.3g/24h or ≥2 crosses with labstix®) with or without edema and/Or patients with one or more complications occurring in the context of preeclampsia. Out of 5671 births were reported during this period, a total of 660 cases of all the records of hypertension associated with pregnancy was collected, out of which 401 cases had preeclampsia. The data information were abstracted from the medical record and supplemented with data collected specifically for the study, that were processed by a statistical study using the Statistical Software Package for Social Science (SPSS) software version (16.0). A univariate analysis was performed in order to reveal the characteristics of the population studied. Chosen parameters were: frequency, maternal age, gestational age, (medical, obstetric, gynecological and surgical) history, parity and monitoring of pregnancy. A bivariate analysis was performed to identify factors of poor maternal prognosis. The occurrence of complications (maternal or fetal accident) was considered as the variable to be explained and the other variables as explanatory variables. We used the Chi-2 square test to analyze the qualitative variables and Student and Anova tests (analysis of variances) for the quantitative variables. The significance level was set at 5% (p <0.05: was considered statistically significant). Ethics: informed consent approved by the University Hassan II comity of ethics, was obtained from each patient included in this study.

 

 

Univariate analysis

 

Frequency: out of 5671 births registered, 660 cases of hypertension associated with pregnancy are recorded, out of which 401 cases have preeclampsia (Table 1). Preeclampsia (either pure or added) represents 60.76% of HTAs encountered in our department during the study period, with a frequency of 7.07%.

 

Maternal age: the average age of pre-eclampsia patients is 30 years with extremes ranging from 15 to 47 years. The range of age group most affected is between 24 and 34 years old (47.38%), followed by the age group of 35 to 47 years (31.92%). Patients aged 15 to 23 years are the least affected (20.70%).

 

Gestational age: the average gestational age on admission found to be 36.2 weeks of gestation with extremes ranging from 24 to 34 SA. More than two thirds of the patients 70.82% have a gestational age (≥ 36 weeks of gestation) (fetal maturity assumed to be acquired); whereas 27.19% are not at term of which 9.23% are far of the term with a gestational age (<32 weeks of gestation) (risk of severe prematurity). For 1.99% of preeclampsia patients, gestational age is not specified.

 

Medical history: of the 401 pre-eclampsia patients included in this study, 74 (18.45%) have a medical history (Table 2). Obesity is the most frequent risk factor in our preeclamptic patients (15.21% of cases) followed by chronic hypertension (5.73% of cases). Some patients have multiple medical history at same time.

 

Obstetric history: of the 401 preeclampsia patients included in this study, 105 (26.18%) have an obstetric history (Table 3). Abortion is the most frequent antecedent in (16.46% of cases). Some patients have several obstetric antecedents at the same time.

 

Gynecological history: only 9 patients have gynecological history in (2.24% of cases), 5 cases with uterine fibroid, 2 cases with ovarian cyst, 1 case with breast nodule and 1 case with uterus bicervical.

 

Surgical history: surgical history is not reported in 8 patients (2%), with 5 cases with cholecystectomy, 1 case with appendectomy, 1 case with intestinal occlusion and 1 case with hydatid cyst of the liver.

 

Parity: preeclamptic patients are classified into three groups according to parity: primiparae (one delivery after 28 weeks), biparae (two to four deliveries) and multiparae (≥ 5 deliveries). More than half of our patients are primiparae (57.61%), 1.7 and 6.8 times more numerous than biparae (33.91%) and multiparae (8.48%) respectively.

 

Pregnancy monitoring: in this study, 133 patients are regularly monitored on the obstetrical level in (33.17% of cases), while two-thirds (268 cases) are not followed (66.83% of cases).

 

Bivariate analysis

 

Factors of poor maternal prognosis: maternal age, gestational age, parity and non-prenatal follow-up are reported as factors of poor maternal prognosis in our study (Table 4).

 

Factors of poor fetal prognosis: poor fetal prognosis factors found in our study are the advanced maternal age and low gestational age (Table 5).

 

 

The frequency of preeclampsia in Casablanca is 7.07%. Moroccans studies noted a variable rate between frequencies found in other cities ranging from 50 to 73% [15]. Therefore, this rate was 44% in sub-Saharan countries 44% [13], compared with developed countries that reported a frequency of 0.5-7% [3, 10, 11]. In our study, the mean maternal age of our preeclamptic patients are 30 years. This trend can be explained by the increased frequency of marriage and early pregnancies in this age group in our context. Young maternal age between 25 and 35 years has been reported to be as a risk factor for preeclampsia in several studies [12]. According to various authors [8], is the advanced maternal age that constitutes a factor of poor maternal prognosis. Numerous studies have reported a risk of preeclampsia multiplied by 2 to 4 for women over 35 years of age [11]. In our study, preeclamptic patients age under than 24 years of age are significantly more at risk of eclampsia, while those aged > 34 years are significantly more at risk for acute renal failure, acute edema of the lung. The frequency of prematurity in our study is significantly higher in our preeclampsic patients over 34 years of age compared to those aged 24 to 34 years and those aged less than 24 years. Thus, we suggest that the advanced maternal age is a factor of poor prognosis in our study. The development of preeclampsia at an early gestational age (<34 weeks of gestation) have been associated with significant maternal and perinatal morbidity and mortality [6]. In our study, preeclampsia patients with a gestational age (<34 weeks of gestation) has worse prognosis compared to those patient with a gestational age (≥34 weeks of gestation), which is often accompanied by complications such as (HELLP Syndrome, eclampsia, retroplacental hematoma, acute renal failure and maternal death). The results show a significantly higher frequency of fetal hypotrophy, prematurity, neonatal distress, neonatal respiratory distress and perinatal death in neonates of patients with a gestational age (<34 weeks of gestation) compared with those of preeclamptic patients having a gestational age (≥ 34 weeks of gestation). Similarly, a recent work has reported the development of preeclampsia at an early gestational age (<34 weeks of gestation) [3]. Thus, early gestational age (<34 weeks of gestation) may be considered as a factor of poor maternal and fetal prognosis. Preeclampsia complicates 2 to 8% of pregnancies worldwide [6]. Much research reported that primigesity and primiparity predispose to preeclampsia: the proportion of preeclampsia is high in primigravida and primipara women, regardless of their age [16]. The incidence of preeclampsia was more frequent in nulliparous than primiparous and multiparous [17]. In our study primiparous as a maternal prognosis are the most exposed group. Similar results have been reported primiparity as a risk factor of preeclampsia and its proportion was variable in the literature [18]. Therefore, other risk factors found in the literature include the advanced maternal age and multiparity [3]. In our study, multiparous preeclampsia patients have more complications compared to primiparous, with a significantly higher frequency of HELLP syndrome. These results support the fact that multiparity is a factor of poor maternal prognosis. In our study, preeclampsia patients present a medical history with high frequency of vasculo-renal antecedents. These antecedents (obesity, hypertension, diabetes, nephropathy, cardiopathy) increase the risk of preeclampsia by the vascular lesions that they determine [8]. Obesity is the most common risk factor, followed by chronic hypertension and diabetes in our study. These three factors have often been presented as a risk factors for pre-eclampsia [19]. In women with pre-gestational diabetes, preeclampsia complicates 10% to 20% of pregnancies, three times more than reported in normal pregnancies with higher risk of preeclampsia in patients with type 1 diabetes and pregestational microalbuminuria [20]. Obesity confers a high risk of fetal and maternal consequences of preeclampsia [21]. In our study, pre-eclampsia patients have an obstetric history in order of frequency: abortion, perinatal death, pre-eclampsia, eclampsia and/or retroplacental hematoma. There is no significant difference in maternal or fetal complications in patients with or without obstetric history. However, gynecological and surgical history are less present in preeclampsia patients. In our study, preeclampsia patients having no obstetric follow-up have a worse prognosis compared to those whose pregnancy was followed, with a significantly higher rate of HELLP syndrome, Eclampsia and maternal death, which is similar to the results found in some other studies that have reported the strong association of the complication of HELLP syndrome with the increased risk of maternal morbidity and mortality [22]. Thus, the non-prenatal follow-up represent a factor of poor maternal prognosis in our study.

 

 

Preeclampsia is still a public health problem due to its high incidence and the presence of many sever cases in our context. It is one of the main causes of maternal and fetal morbidity and mortality. In this study, obesity and chronic hypertension were the most frequent risk factors as a vasculo-renal history, followed by abortion and perinatal death as obstetric history. In this context, only earlier diagnosis and closer monitoring could improve the prognosis of our preeclamptic patients in order to reduce its incidence.

 

 

The authors declare no competing interests.

 

 

Meriem Benfateh, wrote and finalized the manuscript, she was also involved -with the contribution of Souadou Cissoko- in the collection of patients' clinical data from the Department of Gynecology-Obstetrics "C" Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca. Jean-Jacques Feige, Mohamed Benharouga, Naima Samouh provided scientific intellectual contribution. Houssine Boufettal and Touria Aboussaouira, Nadia Alfaidy directed the study; they validated the study protocols and supervised the progress of the whole work. All authors read and approved the final version of the manuscript.

 

 

We would like to thank the staff of the Department of Gynecology-Obstetrics "C" Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca, for their collaboration regarding the collection of clinical data and everyone who participated to this study.

 

 

Table 1: types of preeclampsia according to HTA among the 401 preeclamptic patients studied in the Gynecology-Obstetrics "C" at the Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca (2010-2011)

Table 2: medical history among the 401 preeclamptic patients studied in the Gynecology-Obstetrics "C" at the Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca (2010-2011)

Table 3: obstetric history among the 401 preeclamptic patients studied in the Gynecology-Obstetrics "C" at the Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca (2010-2011)

Table 4: epidemiological factors of poor maternal prognosis among the 401 preeclamptic patients studied in the Gynecology-Obstetrics "C" at the Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca (2010-2011)

Table 5: epidemiological factors of poor fetal prognosis among the 401 preeclamptic patients studied in the Gynecology-Obstetrics "C" at the Service of Lalla Meryem Maternity of Ibn Rochd University Hospital of Casablanca (2010-2011)

 

 

1. Winer N, Tsasaris V. État des connaissances: prise en charge thérapeutique de la pré-éclampsie. J Gynecol Obstet Biol Reprod. 2008; 37(1): 5-15. Google Scholar


2. Alfaidy N, Hoffmann P, Boufettal H, Samouh N, Touria Aboussaouira, Mohamed Benharouga M, Feige J, Brouillet S. The multiple roles of EG VEGF/PROK1 in normal and pathological placental angiogenesis. Bio Med Res Int. 2014; 2014: 451906. PubMed | Google Scholar


3. Garg N, Polipalli SK, Kapoor S. Genetic conflicts and pathophysiological changes in pregnancy: a risk factor for pre-eclampsia. Int J Pharm Sci. 2015; 4(11): 549-583. Google Scholar


4. Curiel-Balsera E, Prieto-Palomino MA, Mu'noz-Bono J, Ruiz de Elvira MJ, Galeas JL, Quesada García G. Analysis of maternal morbidity and mortality among patients admitted to obstetric intensive care with severe preeclampsia, eclampsia or HELLP syndrome. Med Intensiva. 2011; 35(8): 478-483. PubMed | Google Scholar


5. Bartsch E, Medcalf KE, Park AL, Ray JG. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. Br Med J. 2016 Apr 19; 353: i1753. PubMed | Google Scholar


6. Dayer ML, Vocat A, Ditisheim A, Pechère-Bertschi A. Pronostic réno-vasculaire de la prééclampsie chez la mère et l'enfant. Rev Med Suisse. 2013; 9: 1628-1632.


7. Ananth Karumanchi S, Joey Granger P. Preeclampsia and pregnancy-related hypertensive disorders. Hypertension. 2016; 67(2): 238-242. PubMed


8. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation. 2011; 123(24): 1-3. PubMed


9. Dubar G, Rackelboom T, Tsatsaris V, Mignon A. Pré éclampsie, Éclampsie. EMC-Anesthésie-Réanimation. 2012; 9(2): 1-18.


10. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. Br Med J. BMJ. 2013 Nov 7; 347: f6564. PubMed | Google Scholar


11. Goffinet F. Epidemiology. Ann Fr Anesth Reanim. 2010; 29(3): 7-12. PubMed


12. Harioly Nirina MOJ, Rasolonjatovo TY, Andrianirina M, Randriambololona DMA, Ranoaritiana DB, Andrianjatovo JJ, Randriamiarana JM. Profil épidémiologique des pré-éclampsies et des éclampsies admises à la réanimation des adultes de la maternité de Befelatanana. Rev Anest Réa Méd Urg. 2009; 1(3): 22-24. Google Scholar


13. Baragoua S, Goeh-Akueb E, Piob M, Afassinoub YM, Attaa B. Hypertension and pregnancy in Lome (sub-Saharan Africa): Epidemiology, diagnosis and risk factors. Ann Cardiol Angeiol. 2014; 63(3): 145-150. PubMed | Google Scholar


14. Cissé CT, Thiam M, Diagne PM, Moreau JC. Pré-éclampsie en milieu africain: épidémiologie et pronostic au CHU de Dakar, Gynéco, Venue, D'ailleurs. La Lettre du Gynécologue. 2005; n°301: 8-13.


15. Kabbali N, Tachfouti N, Arrayhani M, Harandou M, Tagnaouti M, Bentata Y, Laouad I, Ramdani B, Bayahia R, Oualim Z, Houssaini TS. Outcome assessment of pregnancy-related acute kidney injury in Morocco: a national prospective study. Saudi J Kidney Dis Transpl. 2015; 26(3): 619-24. PubMed | Google Scholar


16. Merviel P, Touzart L, Deslandes V, Delmas M, Coicaud M, Gondry J. Facteurs de risque de la prééclampsie en cas de grossesse unique. J Gynecol Obstet Biol Reprod. 2008; 37(5): 477-482. Google Scholar


17. Gong YH, Jia J, Lu DH, Dai L, Bai Y, Zhou R. Outcome and risk factors of early onset severe preeclampsia. Chin Med J. 2012; 125(14): 2623-2627. PubMed | Google Scholar


18. Diallo JW, Méda N, Ahnoux-Zabsonré A, Ouattara A, Yanogo A, Tougouma SJ, Somé D, Sanou J, Dolo M. Les manifestations oculaires au cours de la pré-éclampsie sévère ou l'éclampsie au Centre Hospitalier Universitaire Sourô Sanou de Bobo Dioulasso. Pan Afr Med J. 2015; 21: 49. Google Scholar


19. Staff AC, Redman CW, Williams D, Leeson P, Moe K, Thilaganathan , Magnus P, Steegers EA, Tsigas EZ, Ness RB, Myatt L, Poston L, Roberts JM. Pregnancy and long-term maternal cardiovascular health progress through harmonization of research cohorts and biobanks. Hypertension. 2016; 67(2): 251-260. PubMed | Google Scholar


20. Castiglioni MT, Valsecchi L, Cavoretto P, Pirola S, Di Piazza L, Maggio L, Caretto A, Garito TS, Rosa S, Scavini M. The risk of preeclampsia beyond the first pregnancy among women with type 1 diabetes parity and preeclampsia in type 1diabetes. Preg Hyper An Int J Women's Card Health. 2014; 4(1): 34-40. PubMed | Google Scholar


21. Aliyu MH, Luke S, Kristensen S, Alio AP, and Salihu HM. Joint effect of obesity and teenage pregnancy on the risk of preeclampsia: a population-based study. J Adolesc Health. 2010; 46(1): 77-82. PubMed | Google Scholar


22. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012; 36(1): 56-59. PubMed | Google Scholar